Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a newer build was deployed. There are no changes to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-28T04:59:33.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - Page revision updated from v3.6.2 to v3.6.3, reflecting a newer build of the page. No content changes are indicated by the provided change data.
    Difference
    0.0%
    Check dated 2026-07-06T16:15:12.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Adverse event reporting language was updated to specify CTCAE version 3.0, require reporting the percentage of patients with grade 3+ adverse events by arm, and establish a 2.5-year follow-up window; registry identifiers and the previous post-treatment window were removed from the study record.
    Difference
    0.3%
    Check dated 2026-06-29T08:52:19.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    New help and navigation sections have been added to the page, including No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment label. The revision note has been updated to v3.6.0 and the older Intervention / Treatment label and Revision: v3.5.5 entry were removed.
    Difference
    0.3%
    Check dated 2026-06-15T08:33:46.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation/versioning rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-08T05:32:19.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4. This is a small metadata update indicating a new build or update to the page, not a substantive change to content.
    Difference
    0.0%
    Check dated 2026-05-18T03:48:31.000Z thumbnail image

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.